Pharmafile Logo

Aqurance

Aqurance consults Life Sciences industry to empower with digital solutions their salesforce, implementing top quality technology platforms, through its strategic partnerships. Founded in September 2011, with offices in Athens and Istanbul, is the fastest growing service provider for Life Sciences in South East Europe.
We believe that the future of Pharma is evidence-based. Our mission is to provide and implement effective tools that will help industry professionals make better and more effective decisions. We aim to facilitate Pharma managers in successfully overcoming budgetary and organizational challenges by using technology and data combined.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

MDNT

MDNT is a native Digital and Omnichannel agency focused solely on the healthcare, pharma, and life science industries. We’re highly experienced, no nonesense, and very good at what we do.

View Profile

Onyx Health

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…

View Profile

OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.

View Profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Company Details

Egiou 1 & Figaleias Athens, Bilim Sokak Sun Plaza Kat: 13 Istanbul, Greece - Turkey, 14564 - 34398
+30 210 6200 206 - +90 212 366 02 40

 Latest Content from PMHub 

Creating accessible health content isn’t easy – but it’s worth it

Press Releases | February 16, 2024 | Wallace Health

If you’re trying to engage patients, here are the big challenges and even bigger rewards that come with being health literacy aware.

We’re now a B Corp!

Press Releases | February 16, 2024 | Wallace Health

PRESS RELEASE: Wallace Health has been certified as B Corporation, a business that pursues purpose as well as profit.

Wallace Health becomes an accredited PIF TICK member

Press Releases | February 16, 2024 | Wallace Health

PRESS RELEASE: Wallace Health gains PIF TICK accreditation to become a ‘trusted information creator’

6 content must-dos for 2024

Press Releases | February 16, 2024 | Wallace Health

What are the key trends and innovations that will shape the way we create health content in 2024?  Here are the six things the Wallace Health team will be focusing on...

5 ways to engage HCPs in medical education

White Papers and Resources | February 16, 2024 | Wiley

How to bring credibility, trust and flexibility into your medical education programs

Navigating challenges of MedTech research with rare-disease patients

White Papers and Resources | February 16, 2024 | Inizio

Authored by: Tom Donnelly, MedTech Director and Amanda Pirraglia, Associate Director. Published in Quirk's Magazine.

Did You Hear From Her? If Not Here’s What You Missed in Season 1 of the Award-Winning Season Podcast Series

Press Releases | February 15, 2024 | Medscape Education

What are some of the biggest gaps that women face in healthcare today?  “So many I could talk for hours!” said Shikha Jain, MD, FACP, President, CEO, Founder Women in Medicine....

Have you heard from her?

Press Releases | February 15, 2024 | Medscape Education

We’re referring to the renowned women leaders from across the healthcare landscape who were our guests on Season 1 of Medscape Education’s Hear From Her podcast series. The conversations touched...

Clinical trial considerations: Why diversity matters…

Diversity in clinical trials is crucial for understanding diseases and developing new treatments. Here's why diversity matters...